Abstract:Objective:The present study aimed to investigate the expressions of P16,P15,and vascular endothelial growth factor(VEGF) in primary epithelial ovarian carcinoma as well as their relationship with clinicopathological features.Methods: P16,P15,and VEGF proteins were detected in 170 cases of primary epithelial ovarian carcinoma,60 cases of borderline tumors,and 60 cases of benign tumors by using S-P immunohistochemical staining method.Result: In ovarian carcinoma,the positive expression rate of P16 was 40.0%.This rate was lower than that in benign tumors(65.0%) and borderline tumors(56.7%;P<0.05).In epithelial ovarian carcinoma,the positive expression rate of P15 was 45.3%.This rate was also lower than that in benign tumors(68.3%) and borderline tumors(61.7%;P<0.05).In epithelial ovarian carcinoma,the positive expression rate of VEGF was 71.2%.This was higher than that in benign tumors(45.0%) and borderline tumors(53.3%;P<0.05).In ovarian carcinoma,P16 expression was positively correlated with P15(r=0.294;P<0.01),but VEGF expression was negatively correlated with P16 and P15(r=-0.461;r=-0.251;P<0.01).The expressions of these three proteins were significantly correlated with the degree of tumor differentiation,clinical stage,and lymph node metastasis.In lymph node metastasis,high clinical stage,or poor differentiation,low positive rates of P16 and P15 were observed(P<0.05).For VEGF,the positive rate was high.P16 and P15 expressions were not correlated with vascular invasion.VEGF expression was higher in the vascular invasion group than in the non-vascular invasion group.Conclusion: Low P16 and P15 expressions as well as high VEGF expression may exhibit synergistic effects on the development of ovarian carcinoma and simultaneously promote malignant development of ovarian carcinoma.

The Amplification and Protein Expression of AIB1 Gene and Its Clinical Significance in Ovarian Cancer

[Expression of AIB1 protein in epithelial ovarian cancer cells and its impact on apoptosis].

Correlation of expression of AIB1 protein with ER and PR in epithelial ovarian cancer

A Study on the Expression and Clinical Significance of AIB1 Protein in Ovarian Borderline Epithelial Tumor

[Expression of AIB1 Protein in Gynecological Tumors].

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Correlation of AIB1 Overexpression with Advanced Clinical Stage of Human Colorectal Carcinoma

AIB1 Genomic Amplification Predicts Poor Clinical Outcomes in Female Glioma Patients.

AIB1 expression in cervical cancer

Expression of AIB1 Protein in Carcinoma of Endometrium

Overexpression of AIB1 Negatively Affects Survival of Surgically Resected Non-Small-cell Lung Cancer Patients.

Expression of aurora-A gene in ovarian cancer tissue and its clinicopathologic significance

Frequent Amplification of AIB1, a Critical Oncogene Modulating Major Signaling Pathways, is Associated with Poor Survival in Gastric Cancer

[Expression and Clinical Significance of DNAJB11 in Epithelial Ovarian Cancer].

Protein Expression and Amplification of AIB1 in Human Urothelial Carcinoma of the Bladder and Overexpression of AIB1 is a New Independent Prognostic Marker of Patient Survival

The expression and clinical significance of amplified in breast cancer 1 protein in thyroid tumor tissues

Correlation research of AIB1 expression and prognosis of breast cancer

Overexpression of AIB1 in Nasopharyngeal Carcinomas Correlates Closely with Advanced Tumor Stage.

AIB1 predicts tumor response to definitive chemoradiotherapy and prognosis in cervical squamous cell carcinoma.

Expression and Amplification of Eif-5a2 in Human Epithelial Ovarian Tumors and Overexpression of Eif-5a2 is A New Independent Predictor of Outcome in Patients with Ovarian Carcinoma

Expression of NOB1 Gene and Its Clinical Significance in Ovarian Cancer